Simulations Plus Receives U.S. FDA Renewal for DILIsym Software Licenses
Go back to Simulations Plus Receives U.S. FDA Renewal for DILIsym Software Licenses| SIMULATIONS PLUS, Inc. (NASDAQ: SLP) | Delayed: 18.32 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.32 | 52 Week High | $11.89 | |||
| Open | $18.32 | 52 Week Low | $6.74 | |||
| Day High | $18.32 | P/E | 101.78 | |||
| Day Low | $18.32 | EPS | $0.18 | |||
| Volume | 471 | |||||
